Dopamine negatively modulates its own blood pressure increasing action

Area of Science:

• Pharmacology
• Cardiovascular Physiology
• Biochemistry

Background:

• Dopamine is a neurotransmitter and hormone with complex cardiovascular effects.
• Understanding dopamine's hypertensive mechanisms and metabolic influences is crucial for clinical applications.

Purpose of the Study:

• To investigate the mechanisms underlying dopamine's hypertensive action.
• To determine the role of dopamine's metabolic pathways in its blood pressure effects.

Main Methods:

• Healthy subjects received a borderline hypertensive dose of free dopamine via infusion.
• Plasma concentrations of dopamine, norepinephrine, and key dopamine metabolites (3-4-dihydroxyphenylacetic acid, homovanillic acid, dopamine sulfate) were measured.
• Blood pressure responses (systolic and diastolic) were monitored throughout the infusion and post-infusion periods.

Main Results:

• Dopamine infusion moderately increased systolic and diastolic blood pressure, accompanied by elevated free dopamine and norepinephrine.
• Significant increases in dopamine metabolites, particularly dopamine sulfate, were observed, with delayed generation correlating with decreased diastolic blood pressure.
• Blood pressure responders showed delayed dopamine sulfate generation, while non-responders generated it immediately.
• Systolic blood pressure changes negatively correlated with free dopamine and dopamine sulfate levels.

Conclusions:

• The 4 µg/kg/min dopamine infusion rate elevates blood pressure indirectly through norepinephrine.
• Free dopamine and dopamine sulfate act as negative modulators of dopamine-induced hypertension.
• The rate of dopamine sulfate generation might be an inherited factor influencing blood pressure response.